Navigation Links
Shock tactics: Bioelectrical therapy for cancer and birth defects?
Date:10/18/2010

Stem cell therapies hold increasing promise as a cure for multiple diseases. But the massive potential of a healthy stem cell has a flip side, as faulty regulation of stem cells leads to a huge range of human diseases. Even before birth, mistakes made by the stem cells of the foetus are a major cause of congenital defects, and cancer is also caused by the body losing control of stem cell function. Guiding stem cells along the correct pathways and, where necessary, reversing their mistakes is the goal of everyone in this field. Now, Michael Levin (http://www.drmichaellevin.org/) and colleagues from Tufts University (http://www.tufts.edu/), Medford, MA, have identified a novel and readily modifiable signal by which an organism can control the behaviour of stem cell offspring. Their work is published in Disease Models & Mechanisms on October 19th, 2010, at http://dmm.biologists.org/.

Levin's laboratory works on an intriguing phenomenon: bioelectrical signalling. There is always a difference in voltage, called the transmembrane potential, between the inside and outside of all cells, and controlling exactly what this difference is turns out to be vitally important. Specialised protein checkpoints sited in a cell's outer membrane regulate ion flow in and out of the cell, producing voltage gradients. These, combined with more conventional protein-based signalling systems, can specify cell destiny.

Levin's team already knew from collaborative work with David Kaplan's lab, also at Tufts, that the properties of human stem cells growing in artificial culture could be drastically altered by changing their transmembrane potential. Now they have taken this work one important step further, by asking whether tampering with the transmembrane potential of one kind of cell can have a domino effect in a whole organism, altering the destiny of other cell types. To do this, they focused on the development of neural crest stem cells, which are responsible for directing development of the face and heart, but which also generate melanocytes, the pigment cells of the skin. Using frog tadpoles and melanocytes as a model system, they showed that tweaking the transmembrane potential of a tiny population of 'instructor' cells sends a signal to developing melanocytes that causes them to overgrow and start to resemble metastatic cancer cells. Most excitingly, they found that the signal can travel over long distances in the tadpole, and that the messenger carrying it is serotonin an important neurotransmitter involved in mood regulation and many other aspects of nervous system function.

This novel bioelectrical method of changing stem cell behaviour has huge implications. It is very likely that there are similar 'instructor' cells that direct other important cell populations, and changing their voltage gradients would be relatively easy (Levin's lab simply used an anti-parasitic drug already available on prescription). The resulting bioelectrical therapy could potentially be harnessed to improve regenerative repair after injury, repair birth defects and detect and prevent cancer.


'/>"/>

Contact: Sarah Allan
sarah.allan@biologists.com
The Company of Biologists
Source:Eurekalert

Related biology news :

1. Molecular mechanism of anaphylactic shock decoded
2. Shock and kill research gives new hope for HIV-1 eradication
3. Targeting helpers of heat shock proteins could help treat cancer, cardiovascular disease
4. Septic shock: Nitric oxide beneficial after all
5. Kapahi to receive GSAs 2010 Nathan Shock New Investigator Award
6. Breast cancer cells recycle to escape death by hormonal therapy
7. On the trail of a targeted therapy for blood cancers
8. Researchers identify promising gene target for neuroblastoma therapy
9. Gene therapy restores vision to mice with retinal degeneration
10. How eating fruit and vegetables can improve cancer patients response to chemotherapy
11. Researchers at UH explore use of fat cells as heart attack therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... ... April 18, 2017 , ... ... been a key device for generating monodisperse droplets of known diameters for research ... for generating monodisperse solid particles by drying monodisperse droplets. , The VOAG ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces ... Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , ... 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the ...
(Date:4/19/2017)... , April 19, 2017 A new report published by ... Forecast, 2014-2022 ," the global market was valued at $6,769 million in 2015, ... 9.6% from 2016 to 2022. ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) The ...
(Date:4/19/2017)... Mass. , April 19, 2017   ... results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) ... print issue of Critical Care Medicine . ... Mortality in Severe Sepsis Patients: Results From the ... use of the B·R·A·H·M·S PCT (procalcitonin) assay to ...
Breaking Biology Technology: